Clinical implications of the contrasting effects of in vivo thrombin receptor activation (protease-activated receptor type 1) on the human vasculature.
Cleator
John H
JH
Vaughan
Douglas E
DE
D001161:Arteriosclerosis / Q000378:metabolism / Q000503:physiopathology*; D004730:Endothelium, Vascular / Q000378:metabolism / Q000503:physiopathology*; D006801:Humans; D009130:Muscle, Smooth; D044463:Receptor, PAR-1 / Q000378:metabolism*; D018179:Receptors, Thrombin / Q000378:metabolism*; D013917:Thrombin / Q000378:metabolism*; D014661:Vasoconstriction; D014664:Vasodilation
D044463:Receptor, PAR-1; D018179:Receptors, Thrombin; D013917:Thrombin